{"gene":"NPHS1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1999,"finding":"The NPHS1 gene encodes nephrin, a transmembrane protein expressed on podocytes. The gene consists of 29 exons spanning 26 kb on chromosome 19q13.1. Loss-of-function mutations (including the Finnish Fin-major 2-bp deletion in exon 2 and Fin-minor nonsense mutation in exon 26) cause congenital nephrotic syndrome of the Finnish type.","method":"Genomic structure analysis, direct exon sequencing, mutation characterization in 35 NPHS1 patients","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational structural characterization of the gene replicated across multiple patient cohorts and confirmed by multiple subsequent studies","pmids":["9915943"],"is_preprint":false},{"year":2000,"finding":"Fin-major and Fin-minor mutations in NPHS1 both lead to complete absence of nephrin protein in podocytes and loss of podocyte slit diaphragms, while ZO-1 (another slit diaphragm-associated protein) stains normally. A patient with Fin-major/R743C genotype expressed nephrin, had normal slit diaphragms, and responded to therapy, establishing that nephrin is required for slit diaphragm formation.","method":"Immunohistochemistry, Western blotting, in situ hybridization, electron microscopy of nephrectomized kidneys from 46 Finnish NPHS1 patients","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (IHC, WB, ISH, EM) in a large patient cohort with genotype-phenotype correlation","pmids":["10972661"],"is_preprint":false},{"year":2001,"finding":"Missense mutations in NPHS1 result in nephrin protein being retained in the endoplasmic reticulum (ER) and failing to reach the cell surface, indicating that defective intracellular nephrin transport (most likely due to misfolding) is the most common pathomechanism of missense mutations in NPHS1.","method":"Stable transfection of cells expressing 21 nephrin missense mutants, immunostaining, immunoelectron microscopy, subcellular fractionation","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic in vitro functional analysis with multiple orthogonal methods (immunostaining, immunoelectron microscopy, subcellular fractionation) across 21 different mutations","pmids":["11726550"],"is_preprint":false},{"year":2001,"finding":"Recurrence of nephrotic syndrome after kidney transplantation in NPHS1 patients is caused by circulating autoantibodies against nephrin. Serial serum samples showed increased anti-nephrin antibody titers prior to nephrotic syndrome episodes and subsequent drops after successful treatment, with high-titer sera reacting with glomeruli in indirect immunofluorescence.","method":"Indirect immunofluorescence microscopy, immunoblotting, ELISA using serial serum samples from transplanted NPHS1 patients","journal":"Experimental nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (IF, immunoblot, ELISA) in a single lab with serial patient samples demonstrating correlation between antibody titer and disease recurrence","pmids":["11549850"],"is_preprint":false},{"year":2000,"finding":"An 8.3-kb fragment of the murine Nphs1 5' flanking region (promoter) drives podocyte-specific expression of a lacZ reporter transgene in kidneys, with additional expression in a discrete area of the brain medulla, establishing the Nphs1 promoter as a tool for podocyte-specific transgene expression.","method":"BAC clone identification, transgenic mouse generation with LacZ reporter, chemiluminescence assay, X-gal staining of tissue sections, developmental expression analysis","journal":"Journal of the American Society of Nephrology : JASN","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo localization experiment with multiple transgenic founders confirming integration-independent expression pattern","pmids":["11095653"],"is_preprint":false},{"year":2007,"finding":"Anti-nephrin antibodies in NPHS1 patients homozygous for Fin-major mutation effectively impair glomerular filtration barrier function in kidney grafts, and plasma exchange alongside cyclophosphamide treatment reduces proteinuric episodes, further supporting the pathogenic role of anti-nephrin autoantibodies.","method":"ELISA for anti-nephrin antibodies, light microscopy and immunohistochemistry of kidney biopsies, clinical outcomes analysis of 65 NPHS1 patients with 77 transplants","journal":"Transplantation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ELISA antibody quantification correlated with clinical outcomes in a substantial patient cohort, replicating the 2001 autoantibody finding","pmids":["17519780"],"is_preprint":false},{"year":2002,"finding":"Genetic evidence for a functional inter-relationship between NPHS1 (nephrin) and NPHS2 (podocin) was established through identification of a unique di-genic inheritance pattern where compound mutations in both NPHS1 and NPHS2 ('tri-allelic hit') modify the disease phenotype from congenital nephrotic syndrome to congenital focal segmental glomerulosclerosis.","method":"Genetic epistasis analysis, direct sequencing of NPHS1 and NPHS2 in 41 non-Finnish CNF patients and additional patients with FSGS","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis in human patients, single study establishing functional interaction between NPHS1 and NPHS2 at the pathway level","pmids":["11854170"],"is_preprint":false},{"year":2015,"finding":"Wild-type nephrin suppresses TRPC6 channel currents in HEK293 cells and podocytes, and synonymous NPHS1 polymorphisms (rs2285450, rs437168) abolish this suppressive effect, suggesting that nephrin normally limits TRPC6 activity and that NPHS1 variants can modify the penetrance of TRPC6 mutations.","method":"Patch-clamp electrophysiology in HEK293 cells and podocytes transfected with wild-type or variant TRPC6 and NPHS1 constructs","journal":"American journal of transplantation","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct functional electrophysiology experiment in two cell systems (HEK293 and podocytes), single lab study","pmids":["26147534"],"is_preprint":false},{"year":2018,"finding":"CNS-associated NPHS1 missense mutations A419T and C623F reduce nephrin surface expression, cause ER retention, impair nephrin tyrosine phosphorylation on its cytoplasmic tail, and exert dominant negative effects on wild-type nephrin signaling, revealing that extracellular domain missense mutations can disrupt intracellular nephrin signaling.","method":"Kidney biopsy immunolocalization, stable cell transfection, immunofluorescence, flow cytometry for surface expression, phosphorylation assays, dominant-negative signaling assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (IHC on biopsy, cell surface expression, phosphorylation assays, dominant-negative analysis) in a single lab","pmids":["30212551"],"is_preprint":false},{"year":2013,"finding":"Pathogenic NPHS1 mutations in Japanese patients impair trafficking of nephrin to the plasma membrane, confirmed by transient transfection assays comparing staining with and without detergent permeabilization (Triton X), consistent with the previously established ER-retention mechanism.","method":"Transient transfection, immunostaining with and without Triton X permeabilization, automated counting software","journal":"Histology and histopathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cell-based trafficking assay replicating prior mechanistic findings in a new cohort with a simplified method","pmids":["24142548"],"is_preprint":false},{"year":2024,"finding":"Nphs1 knockout mice (conditional) exhibit effacement of foot processes (mean FP density 1.0 vs. 2.0 FP/µm in controls), reduced filtration slit density, proteinuria within the first week of life, and median survival of 18 days, directly demonstrating that nephrin is required for structural integrity of the podocyte filtration barrier and normal glomerular function in vivo.","method":"Conditional Nphs1 knockout mouse model phenotyping: electron microscopy for foot process density and filtration slit density, urine albumin-to-creatinine ratio, serum albumin, BUN, creatinine","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with multiple defined phenotypic readouts (ultrastructure, proteinuria, survival, serum markers) in a single study","pmids":["38482553"],"is_preprint":false},{"year":2019,"finding":"A novel intronic NPHS1 mutation (c.3286+5G>A) causes aberrant alternative splicing of NPHS1, establishing a splicing defect as a pathomechanism for congenital nephrotic syndrome in this patient.","method":"RT-PCR/splicing analysis of patient-derived samples to confirm aberrant splicing caused by the intronic mutation","journal":"Italian journal of pediatrics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single patient, single lab, splicing assay without detailed functional characterization of downstream consequences","pmids":["31443662"],"is_preprint":false}],"current_model":"NPHS1 encodes nephrin, a transmembrane immunoglobulin-family protein essential for the structure and function of the podocyte slit diaphragm; loss-of-function mutations (including Finnish Fin-major/Fin-minor) abolish nephrin expression and slit diaphragm formation causing massive proteinuria, while most missense mutations cause ER retention and impaired surface trafficking of misfolded nephrin, nephrin also functions as a signaling scaffold whose tyrosine phosphorylation recruits intracellular effectors and whose surface expression negatively regulates TRPC6 channel activity, and its absence in NPHS1 patients treated by transplantation introduces a neoantigen that drives pathogenic anti-nephrin autoantibodies responsible for post-transplant nephrotic recurrence."},"narrative":{"mechanistic_narrative":"NPHS1 encodes nephrin, a podocyte transmembrane protein that is the structural cornerstone of the glomerular slit diaphragm and is required for the integrity of the kidney filtration barrier [PMID:9915943, PMID:10972661]. Loss-of-function mutations, including the Finnish Fin-major and Fin-minor alleles, abolish nephrin protein and slit diaphragm formation, causing congenital nephrotic syndrome of the Finnish type [PMID:9915943, PMID:10972661]; conditional Nphs1 knockout in mice reproduces this with foot process effacement, reduced filtration slit density, early proteinuria, and neonatal lethality [PMID:38482553]. The most common pathomechanism for missense mutations is misfolding-driven endoplasmic reticulum retention that prevents nephrin from reaching the cell surface [PMID:11726550, PMID:24142548], and certain extracellular-domain missense mutations additionally impair tyrosine phosphorylation of the nephrin cytoplasmic tail and act dominant-negatively on wild-type nephrin signaling [PMID:30212551]. Beyond its structural role, surface nephrin functions as a signaling protein whose activity suppresses TRPC6 channel currents, linking NPHS1 variants to modulation of TRPC6-dependent channel activity [PMID:26147534]. In NPHS1 patients lacking nephrin, transplantation of a nephrin-bearing graft elicits pathogenic circulating anti-nephrin autoantibodies that impair the filtration barrier and drive post-transplant nephrotic recurrence [PMID:11549850, PMID:17519780]. Nephrin function is genetically interlinked with podocin (NPHS2), where combined NPHS1/NPHS2 mutations modify the disease phenotype [PMID:11854170].","teleology":[{"year":1999,"claim":"Establishing that NPHS1 encodes a podocyte transmembrane protein and that defined loss-of-function alleles cause congenital nephrotic syndrome answered what gene underlies the Finnish-type disease.","evidence":"Genomic structure analysis and exon sequencing in 35 NPHS1 patients identifying Fin-major and Fin-minor mutations","pmids":["9915943"],"confidence":"High","gaps":["Did not resolve the molecular/structural role of nephrin at the slit diaphragm","No mechanism for how individual mutations disrupt protein function"]},{"year":2000,"claim":"Demonstrating that disease-causing mutations abolish nephrin protein and slit diaphragms while ZO-1 staining is preserved established that nephrin is specifically required for slit diaphragm formation.","evidence":"IHC, Western blot, in situ hybridization, and EM on nephrectomized kidneys from 46 Finnish patients with genotype-phenotype correlation","pmids":["10972661"],"confidence":"High","gaps":["Did not define how nephrin organizes the slit diaphragm molecularly","Did not address trafficking or signaling roles"]},{"year":2000,"claim":"Identification of a podocyte-specific Nphs1 promoter fragment provided a tool to drive podocyte-restricted transgene expression, defining the gene's tissue specificity at the regulatory level.","evidence":"Transgenic mice with an 8.3-kb Nphs1 5' promoter driving lacZ, with X-gal staining and developmental expression analysis","pmids":["11095653"],"confidence":"Medium","gaps":["Did not characterize the transcription factors controlling podocyte-specific expression","Unexplained brain medulla expression"]},{"year":2001,"claim":"Showing that most missense mutants are retained in the ER and fail to reach the cell surface identified defective intracellular trafficking due to misfolding as the dominant pathomechanism of missense alleles.","evidence":"Stable transfection of 21 nephrin missense mutants with immunostaining, immunoelectron microscopy, and subcellular fractionation","pmids":["11726550"],"confidence":"High","gaps":["Did not identify the ER quality-control machinery involved","Did not test whether residual surface protein retains signaling function"]},{"year":2001,"claim":"Linking post-transplant nephrotic recurrence to circulating anti-nephrin antibodies established an autoimmune neoantigen mechanism in nephrin-null patients.","evidence":"Indirect immunofluorescence, immunoblotting, and ELISA on serial sera from transplanted NPHS1 patients with titer-disease correlation","pmids":["11549850"],"confidence":"Medium","gaps":["Single-lab correlative data without proof of direct pathogenic causation","Antibody epitopes on nephrin not mapped"]},{"year":2002,"claim":"Discovery of tri-allelic NPHS1/NPHS2 inheritance modifying the phenotype established a functional pathway-level interaction between nephrin and podocin.","evidence":"Genetic epistasis analysis and sequencing of NPHS1 and NPHS2 in non-Finnish CNF and FSGS patients","pmids":["11854170"],"confidence":"Medium","gaps":["Did not demonstrate physical or biochemical interaction between nephrin and podocin","Mechanism of phenotype modification unresolved"]},{"year":2007,"claim":"Correlating anti-nephrin antibody titers with graft filtration impairment and treatment response reinforced the pathogenic role of the autoantibodies and informed therapeutic intervention.","evidence":"ELISA antibody quantification with biopsy IHC and clinical outcomes in 65 patients across 77 transplants, including plasma exchange and cyclophosphamide","pmids":["17519780"],"confidence":"Medium","gaps":["Correlative clinical data rather than direct mechanistic proof","Did not define how antibody binding disrupts barrier function molecularly"]},{"year":2013,"claim":"Replication of impaired plasma-membrane trafficking in a Japanese cohort confirmed ER retention as a conserved pathomechanism across populations.","evidence":"Transient transfection with permeabilized/non-permeabilized immunostaining and automated counting","pmids":["24142548"],"confidence":"Medium","gaps":["Simplified assay without quantitative surface trafficking measures","No downstream functional consequence assessed"]},{"year":2015,"claim":"Demonstrating that nephrin suppresses TRPC6 channel currents and that synonymous NPHS1 polymorphisms abolish this effect revealed a signaling/channel-regulatory function for nephrin beyond its structural role.","evidence":"Patch-clamp electrophysiology in HEK293 cells and podocytes co-expressing TRPC6 and NPHS1 constructs","pmids":["26147534"],"confidence":"Medium","gaps":["Single-lab study; molecular mechanism of TRPC6 suppression not defined","In vivo relevance of polymorphism effects not established"]},{"year":2018,"claim":"Showing that extracellular-domain missense mutations reduce surface expression, impair cytoplasmic-tail phosphorylation, and act dominant-negatively connected trafficking defects to disrupted nephrin signaling.","evidence":"Biopsy immunolocalization, stable transfection, flow cytometry surface assays, phosphorylation and dominant-negative signaling assays","pmids":["30212551"],"confidence":"Medium","gaps":["Downstream signaling effectors of the phosphorylated tail not identified","Single-lab analysis of two mutations"]},{"year":2019,"claim":"Identification of an intronic mutation causing aberrant splicing extended the mutational spectrum of NPHS1 to splicing defects.","evidence":"RT-PCR/splicing analysis of patient-derived samples","pmids":["31443662"],"confidence":"Low","gaps":["Single patient, single lab without functional characterization of downstream protein consequences","Transcript fate and residual protein not quantified"]},{"year":2024,"claim":"Conditional Nphs1 knockout mice with foot process effacement, proteinuria, and early lethality provided direct in vivo confirmation that nephrin is required for filtration barrier integrity and glomerular function.","evidence":"Conditional knockout phenotyping with EM ultrastructure, urine albumin-to-creatinine ratio, and serum markers","pmids":["38482553"],"confidence":"Medium","gaps":["Did not dissect structural versus signaling contributions in vivo","Mechanism connecting nephrin loss to foot process effacement not resolved"]},{"year":null,"claim":"The intracellular effectors recruited by phosphorylated nephrin and the precise molecular mechanism by which nephrin organizes the slit diaphragm and regulates TRPC6 remain undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified downstream signaling partners of the nephrin cytoplasmic tail in the corpus","No structural model of the nephrin-based slit diaphragm","Molecular basis of TRPC6 suppression unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,1,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,8]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,9]}],"pathway":[{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8]}],"complexes":["slit diaphragm"],"partners":["TRPC6","NPHS2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60500","full_name":"Nephrin","aliases":["Renal glomerulus-specific cell adhesion receptor"],"length_aa":1241,"mass_kda":134.7,"function":"Seems to play a role in the development or function of the kidney glomerular filtration barrier. Regulates glomerular vascular permeability. May anchor the podocyte slit diaphragm to the actin cytoskeleton. Plays a role in skeletal muscle formation through regulation of myoblast fusion (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O60500/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NPHS1","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NPHS1","total_profiled":1310},"omim":[{"mim_id":"620049","title":"NEPHROTIC SYNDROME, TYPE 26; NPHS26","url":"https://www.omim.org/entry/620049"},{"mim_id":"619953","title":"TRANSMEMBRANE PROTEIN 63C; TMEM63C","url":"https://www.omim.org/entry/619953"},{"mim_id":"619263","title":"NEPHROTIC SYNDROME, TYPE 24; NPHS24","url":"https://www.omim.org/entry/619263"},{"mim_id":"619201","title":"NEPHROTIC SYNDROME, TYPE 23; NPHS23","url":"https://www.omim.org/entry/619201"},{"mim_id":"619155","title":"NEPHROTIC SYNDROME, TYPE 22; NPHS22","url":"https://www.omim.org/entry/619155"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"kidney","ntpm":39.8},{"tissue":"pancreas","ntpm":21.5}],"url":"https://www.proteinatlas.org/search/NPHS1"},"hgnc":{"alias_symbol":["CNF","NPHN"],"prev_symbol":[]},"alphafold":{"accession":"O60500","domains":[{"cath_id":"2.60.40.10","chopping":"35-133","consensus_level":"high","plddt":87.3389,"start":35,"end":133},{"cath_id":"2.60.40.10","chopping":"139-238","consensus_level":"high","plddt":88.8725,"start":139,"end":238},{"cath_id":"2.60.40.10","chopping":"242-338","consensus_level":"high","plddt":86.323,"start":242,"end":338},{"cath_id":"2.60.40.10","chopping":"344-436","consensus_level":"high","plddt":85.7101,"start":344,"end":436},{"cath_id":"2.60.40.10","chopping":"444-543","consensus_level":"high","plddt":80.5712,"start":444,"end":543},{"cath_id":"2.60.40.10","chopping":"549-639","consensus_level":"high","plddt":86.7443,"start":549,"end":639},{"cath_id":"2.60.40.10","chopping":"645-737","consensus_level":"medium","plddt":88.4874,"start":645,"end":737},{"cath_id":"2.60.40.10","chopping":"747-836","consensus_level":"medium","plddt":88.2951,"start":747,"end":836},{"cath_id":"2.60.40.10","chopping":"842-938","consensus_level":"high","plddt":87.192,"start":842,"end":938}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60500","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60500-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60500-F1-predicted_aligned_error_v6.png","plddt_mean":77.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NPHS1","jax_strain_url":"https://www.jax.org/strain/search?query=NPHS1"},"sequence":{"accession":"O60500","fasta_url":"https://rest.uniprot.org/uniprotkb/O60500.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60500/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60500"}},"corpus_meta":[{"pmid":"17371932","id":"PMC_17371932","title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).","date":"2007","source":"Pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/17371932","citation_count":316,"is_preprint":false},{"pmid":"9915943","id":"PMC_9915943","title":"Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9915943","citation_count":303,"is_preprint":false},{"pmid":"10972661","id":"PMC_10972661","title":"Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients.","date":"2000","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10972661","citation_count":213,"is_preprint":false},{"pmid":"11854170","id":"PMC_11854170","title":"Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11854170","citation_count":200,"is_preprint":false},{"pmid":"12538773","id":"PMC_12538773","title":"Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12538773","citation_count":172,"is_preprint":false},{"pmid":"11317351","id":"PMC_11317351","title":"Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome.","date":"2001","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11317351","citation_count":138,"is_preprint":false},{"pmid":"11726550","id":"PMC_11726550","title":"Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11726550","citation_count":124,"is_preprint":false},{"pmid":"11349064","id":"PMC_11349064","title":"Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.","date":"2001","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11349064","citation_count":113,"is_preprint":false},{"pmid":"1968978","id":"PMC_1968978","title":"Virulence factors of bacteraemic Escherichia coli with particular reference to production of cytotoxic necrotising factor (CNF) by P-fimbriate strains.","date":"1990","source":"Journal of medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/1968978","citation_count":70,"is_preprint":false},{"pmid":"15780077","id":"PMC_15780077","title":"Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome.","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15780077","citation_count":63,"is_preprint":false},{"pmid":"20172850","id":"PMC_20172850","title":"Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS).","date":"2010","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/20172850","citation_count":63,"is_preprint":false},{"pmid":"11095653","id":"PMC_11095653","title":"Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 5' flanking region drives LacZ expression in podocytes.","date":"2000","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/11095653","citation_count":63,"is_preprint":false},{"pmid":"18503012","id":"PMC_18503012","title":"Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18503012","citation_count":60,"is_preprint":false},{"pmid":"32554042","id":"PMC_32554042","title":"Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome.","date":"2020","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/32554042","citation_count":48,"is_preprint":false},{"pmid":"9639039","id":"PMC_9639039","title":"Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.","date":"1998","source":"Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/9639039","citation_count":46,"is_preprint":false},{"pmid":"15086927","id":"PMC_15086927","title":"Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS).","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15086927","citation_count":45,"is_preprint":false},{"pmid":"25427594","id":"PMC_25427594","title":"A review: potential usage of cellulose nanofibers (CNF) for enzyme immobilization via covalent interactions.","date":"2014","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/25427594","citation_count":42,"is_preprint":false},{"pmid":"15338398","id":"PMC_15338398","title":"No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations.","date":"2004","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/15338398","citation_count":39,"is_preprint":false},{"pmid":"22565185","id":"PMC_22565185","title":"A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22565185","citation_count":36,"is_preprint":false},{"pmid":"19406966","id":"PMC_19406966","title":"Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.","date":"2009","source":"Clinical journal of the American Society of Nephrology : CJASN","url":"https://pubmed.ncbi.nlm.nih.gov/19406966","citation_count":34,"is_preprint":false},{"pmid":"15549605","id":"PMC_15549605","title":"CNF and DNT.","date":"2004","source":"Reviews of physiology, biochemistry and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15549605","citation_count":33,"is_preprint":false},{"pmid":"16941028","id":"PMC_16941028","title":"Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1).","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16941028","citation_count":33,"is_preprint":false},{"pmid":"11549850","id":"PMC_11549850","title":"Recurrence of nephrotic syndrome after transplantation in CNF is due to autoantibodies to nephrin.","date":"2001","source":"Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/11549850","citation_count":32,"is_preprint":false},{"pmid":"30901196","id":"PMC_30901196","title":"Influence of Cellulose Charge on Bacteria Adhesion and Viability to PVAm/CNF/PVAm-Modified Cellulose Model Surfaces.","date":"2019","source":"Biomacromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30901196","citation_count":31,"is_preprint":false},{"pmid":"31139264","id":"PMC_31139264","title":"Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses.","date":"2019","source":"Gut pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31139264","citation_count":30,"is_preprint":false},{"pmid":"17519780","id":"PMC_17519780","title":"Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1).","date":"2007","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/17519780","citation_count":29,"is_preprint":false},{"pmid":"32829853","id":"PMC_32829853","title":"Facile synthesis of a Co/Fe bi-MOFs/CNF membrane nanocomposite and its application in the degradation of tetrabromobisphenol A.","date":"2020","source":"Carbohydrate polymers","url":"https://pubmed.ncbi.nlm.nih.gov/32829853","citation_count":29,"is_preprint":false},{"pmid":"17211152","id":"PMC_17211152","title":"NPHS1 and NPHS2 gene mutations in Chinese children with sporadic nephrotic syndrome.","date":"2007","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17211152","citation_count":28,"is_preprint":false},{"pmid":"22584503","id":"PMC_22584503","title":"Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients.","date":"2012","source":"Nephron. Clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/22584503","citation_count":25,"is_preprint":false},{"pmid":"30960233","id":"PMC_30960233","title":"Effect of Cellulose Nanofiber (CNF) Surface Treatment on Cellular Structures and Mechanical Properties of Polypropylene/CNF Nanocomposite Foams via Core-Back Foam Injection Molding.","date":"2019","source":"Polymers","url":"https://pubmed.ncbi.nlm.nih.gov/30960233","citation_count":24,"is_preprint":false},{"pmid":"29225701","id":"PMC_29225701","title":"Cytotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor (CNF) colonize laboratory macaques.","date":"2017","source":"Gut pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/29225701","citation_count":24,"is_preprint":false},{"pmid":"7693621","id":"PMC_7693621","title":"Congenital nephrosis of the Finnish type (CNF): matrix components of the glomerular basement membranes and of cultured mesangial cells.","date":"1993","source":"The Histochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7693621","citation_count":24,"is_preprint":false},{"pmid":"26147534","id":"PMC_26147534","title":"Genetic Interactions Between TRPC6 and NPHS1 Variants Affect Posttransplant Risk of Recurrent Focal Segmental Glomerulosclerosis.","date":"2015","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/26147534","citation_count":22,"is_preprint":false},{"pmid":"3894279","id":"PMC_3894279","title":"A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.","date":"1985","source":"Investigational new drugs","url":"https://pubmed.ncbi.nlm.nih.gov/3894279","citation_count":19,"is_preprint":false},{"pmid":"18048423","id":"PMC_18048423","title":"Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1).","date":"2007","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18048423","citation_count":18,"is_preprint":false},{"pmid":"24861644","id":"PMC_24861644","title":"Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.","date":"2014","source":"Journal of infection and public health","url":"https://pubmed.ncbi.nlm.nih.gov/24861644","citation_count":18,"is_preprint":false},{"pmid":"31216994","id":"PMC_31216994","title":"A comprehensive analysis of NPHS1 gene mutations in patients with sporadic focal segmental glomerulosclerosis.","date":"2019","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31216994","citation_count":17,"is_preprint":false},{"pmid":"21414970","id":"PMC_21414970","title":"Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.","date":"2011","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/21414970","citation_count":17,"is_preprint":false},{"pmid":"23325127","id":"PMC_23325127","title":"Glomerulopathy and mutations in NPHS1 and KIRREL2 in soft-coated Wheaten Terrier dogs.","date":"2013","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/23325127","citation_count":16,"is_preprint":false},{"pmid":"33410511","id":"PMC_33410511","title":"Crystal structure of bacterial cytotoxic necrotizing factor CNFY reveals molecular building blocks for intoxication.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33410511","citation_count":14,"is_preprint":false},{"pmid":"20138859","id":"PMC_20138859","title":"Association between genetic polymorphisms of the NPHS1 gene and membranous glomerulonephritis in the Taiwanese population.","date":"2010","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20138859","citation_count":13,"is_preprint":false},{"pmid":"16362719","id":"PMC_16362719","title":"Muscular dystonia and athetosis in six patients with congenital nephrotic syndrome of the Finnish type (NPHS1).","date":"2005","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/16362719","citation_count":13,"is_preprint":false},{"pmid":"24856380","id":"PMC_24856380","title":"Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.","date":"2014","source":"Bosnian journal of basic medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24856380","citation_count":13,"is_preprint":false},{"pmid":"17413422","id":"PMC_17413422","title":"Misleading findings of homozygosity mapping resulting from three novel mutations in NPHS1 encoding nephrin in a highly inbred community.","date":"2007","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17413422","citation_count":13,"is_preprint":false},{"pmid":"8661053","id":"PMC_8661053","title":"Assembly of a 1-Mb restriction-mapped cosmid contig spanning the candidate region for Finnish congenital nephrosis (NPHS1) in 19q13.1.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661053","citation_count":13,"is_preprint":false},{"pmid":"12920248","id":"PMC_12920248","title":"Genetic polymorphism of NPHS1 modifies the clinical manifestations of Ig A nephropathy.","date":"2003","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12920248","citation_count":12,"is_preprint":false},{"pmid":"16316524","id":"PMC_16316524","title":"[NPHS1 mutations in a Chinese family with congenital nephrotic syndrome].","date":"2005","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/16316524","citation_count":12,"is_preprint":false},{"pmid":"10629646","id":"PMC_10629646","title":"Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.","date":"1999","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10629646","citation_count":12,"is_preprint":false},{"pmid":"26560236","id":"PMC_26560236","title":"NPHS1 gene mutations confirm congenital nephrotic syndrome in four Brazilian cases: A novel mutation is described.","date":"2016","source":"Nephrology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/26560236","citation_count":11,"is_preprint":false},{"pmid":"38943949","id":"PMC_38943949","title":"Hydrophobic corn zein-modified cellulose nanofibril (CNF) films with antioxidant properties.","date":"2024","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38943949","citation_count":10,"is_preprint":false},{"pmid":"22009864","id":"PMC_22009864","title":"Two novel NPHS1 mutations in a Chinese family with congenital nephrotic syndrome.","date":"2011","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/22009864","citation_count":10,"is_preprint":false},{"pmid":"29371399","id":"PMC_29371399","title":"Modular domain swapping among the bacterial cytotoxic necrotizing factor (CNF) family for efficient cargo delivery into mammalian cells.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29371399","citation_count":10,"is_preprint":false},{"pmid":"30924936","id":"PMC_30924936","title":"Cellulose nanofiber (CNF)-sakacin-A active material: production, characterization and application in storage trials of smoked salmon.","date":"2019","source":"Journal of the science of food and agriculture","url":"https://pubmed.ncbi.nlm.nih.gov/30924936","citation_count":10,"is_preprint":false},{"pmid":"30979135","id":"PMC_30979135","title":"Synthesis of Polyaniline (PANI) in Nano-Reaction Field of Cellulose Nanofiber (CNF), and Carbonization.","date":"2016","source":"Polymers","url":"https://pubmed.ncbi.nlm.nih.gov/30979135","citation_count":10,"is_preprint":false},{"pmid":"19321760","id":"PMC_19321760","title":"NPHS1 gene mutation in Japanese patients with congenital nephrotic syndrome.","date":"2009","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/19321760","citation_count":9,"is_preprint":false},{"pmid":"37376399","id":"PMC_37376399","title":"Self-Assembled CNF/rGO/Tannin Composite: Study of the Physicochemical and Wound Healing Properties.","date":"2023","source":"Polymers","url":"https://pubmed.ncbi.nlm.nih.gov/37376399","citation_count":9,"is_preprint":false},{"pmid":"30013592","id":"PMC_30013592","title":"Screening of the LAMB2, WT1, NPHS1, and NPHS2 Genes in Pediatric Nephrotic Syndrome.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30013592","citation_count":9,"is_preprint":false},{"pmid":"2192065","id":"PMC_2192065","title":"Detection of cytotoxic necrotising factor (CNF) in extracts of Escherichia coli strains by enzyme-linked immunosorbent assay.","date":"1990","source":"Journal of medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/2192065","citation_count":9,"is_preprint":false},{"pmid":"1510341","id":"PMC_1510341","title":"[Virulence factors and phenotypes of sixty-one strains of Escherichia coli of bovine origin, producing cytotoxic necrotising toxin type 1 (CNF 1)].","date":"1992","source":"Annales de recherches veterinaires. Annals of veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/1510341","citation_count":9,"is_preprint":false},{"pmid":"35278126","id":"PMC_35278126","title":"Spectrum of NPHS1 and NPHS2 variants in egyptian children with focal segmental glomerular sclerosis: identification of six novel variants and founder effect.","date":"2022","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/35278126","citation_count":8,"is_preprint":false},{"pmid":"30212551","id":"PMC_30212551","title":"Characterization of a novel disease-associated mutation within NPHS1 and its effects on nephrin phosphorylation and signaling.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30212551","citation_count":8,"is_preprint":false},{"pmid":"15177566","id":"PMC_15177566","title":"Molecular cloning and characterization of an endogenous antisense transcript of Nphs1.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15177566","citation_count":8,"is_preprint":false},{"pmid":"31963805","id":"PMC_31963805","title":"Electrospun CNF Supported Ceramics as Electrochemical Catalysts for Water Splitting and Fuel Cell: A Review.","date":"2020","source":"Polymers","url":"https://pubmed.ncbi.nlm.nih.gov/31963805","citation_count":8,"is_preprint":false},{"pmid":"25729976","id":"PMC_25729976","title":"Novel NPHS1 splice site mutations in a Chinese child with congenital nephrotic syndrome.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25729976","citation_count":8,"is_preprint":false},{"pmid":"19878023","id":"PMC_19878023","title":"Prevalence of urovirulence genes cnf, hlyD, sfa/foc, and papGIII in fecal Escherichia coli from healthy dogs and their owners.","date":"2009","source":"American journal of veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/19878023","citation_count":8,"is_preprint":false},{"pmid":"22653594","id":"PMC_22653594","title":"Mutations in NPHS1 in a Chinese child with congenital nephrotic syndrome.","date":"2012","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/22653594","citation_count":7,"is_preprint":false},{"pmid":"7684711","id":"PMC_7684711","title":"Prenatal diagnosis of congenital nephrosis of the Finnish type (CNF) in the second trimester.","date":"1993","source":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","url":"https://pubmed.ncbi.nlm.nih.gov/7684711","citation_count":7,"is_preprint":false},{"pmid":"29859279","id":"PMC_29859279","title":"Enzyme treated CNF biofilms: Characterization.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/29859279","citation_count":6,"is_preprint":false},{"pmid":"32471989","id":"PMC_32471989","title":"Spatio-temporal patterning of different connexins in developing and postnatal human kidneys and in nephrotic syndrome of the Finnish type (CNF).","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32471989","citation_count":6,"is_preprint":false},{"pmid":"16703378","id":"PMC_16703378","title":"Neonatal nephrotic presentation of a child with heterozygous NPHS1 mutation.","date":"2006","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/16703378","citation_count":6,"is_preprint":false},{"pmid":"31549796","id":"PMC_31549796","title":"Fe3 SnC@CNF: A 3 D Antiperovskite Intermetallic Carbide System as a New Robust High-Capacity Lithium-Ion Battery Anode.","date":"2019","source":"ChemSusChem","url":"https://pubmed.ncbi.nlm.nih.gov/31549796","citation_count":6,"is_preprint":false},{"pmid":"36460143","id":"PMC_36460143","title":"Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo.","date":"2022","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36460143","citation_count":5,"is_preprint":false},{"pmid":"27882743","id":"PMC_27882743","title":"Congenital nephrotic syndrome with a novel NPHS1 mutation.","date":"2016","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/27882743","citation_count":5,"is_preprint":false},{"pmid":"33014689","id":"PMC_33014689","title":"AuNPs/CNF-modified DNA biosensor for early and quick detection of O. tsutsugamushi in patients suffering from scrub typhus.","date":"2020","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/33014689","citation_count":5,"is_preprint":false},{"pmid":"39451425","id":"PMC_39451425","title":"Characterization of MSC Growth, Differentiation, and EV Production in CNF Hydrogels Under Static and Dynamic Cultures in Hypoxic and Normoxic Conditions.","date":"2024","source":"Bioengineering (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39451425","citation_count":5,"is_preprint":false},{"pmid":"25711261","id":"PMC_25711261","title":"Congenital nephrotic syndrome of NPHS1 associated with cardiac malformation.","date":"2015","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/25711261","citation_count":5,"is_preprint":false},{"pmid":"22221426","id":"PMC_22221426","title":"Durability test with fuel starvation using a Pt/CNF catalyst in PEMFC.","date":"2012","source":"Nanoscale research letters","url":"https://pubmed.ncbi.nlm.nih.gov/22221426","citation_count":5,"is_preprint":false},{"pmid":"25599733","id":"PMC_25599733","title":"Association between NPHS1 and NPHS2 gene variants and nephrotic syndrome in children.","date":"2015","source":"Iranian journal of kidney diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25599733","citation_count":4,"is_preprint":false},{"pmid":"36474550","id":"PMC_36474550","title":"The Distribution of Cytotoxic Necrotizing Factors (CNF-1, CNF-2, CNF-3) and Cytolethal Distending Toxins (CDT-1, CDT-2, CDT-3, CDT-4) in Escherichia coli Isolates Isolated from Extraintestinal Infections and the Determination of their Phylogenetic Relationship by PFGE.","date":"2022","source":"International journal of clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/36474550","citation_count":4,"is_preprint":false},{"pmid":"20802786","id":"PMC_20802786","title":"Investigation into Photoconductivity in Single CNF/TiO(2)-Dye Core-Shell Nanowire Devices.","date":"2010","source":"Nanoscale research letters","url":"https://pubmed.ncbi.nlm.nih.gov/20802786","citation_count":4,"is_preprint":false},{"pmid":"34555552","id":"PMC_34555552","title":"The association of NPHS1 and ACNT4 gene polymorphisms with pre-eclampsia.","date":"2021","source":"European journal of obstetrics, gynecology, and reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/34555552","citation_count":3,"is_preprint":false},{"pmid":"19946311","id":"PMC_19946311","title":"Expanding the spectrum of NPHS1-associated disease.","date":"2009","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/19946311","citation_count":3,"is_preprint":false},{"pmid":"30171708","id":"PMC_30171708","title":"Novel variations in NPHS1 gene in children of South Indian population and its association with primary nephrotic syndrome.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30171708","citation_count":3,"is_preprint":false},{"pmid":"30738309","id":"PMC_30738309","title":"Enhanced photovoltaic properties of dye-sensitized solar cells using three-component CNF/TiO2/Au heterostructure.","date":"2019","source":"Journal of colloid and interface science","url":"https://pubmed.ncbi.nlm.nih.gov/30738309","citation_count":3,"is_preprint":false},{"pmid":"29663071","id":"PMC_29663071","title":"Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1.","date":"2018","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/29663071","citation_count":3,"is_preprint":false},{"pmid":"38482553","id":"PMC_38482553","title":"Quantitative phenotyping of Nphs1 knockout mice as a prerequisite for gene replacement studies.","date":"2024","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38482553","citation_count":2,"is_preprint":false},{"pmid":"36800604","id":"PMC_36800604","title":"A novel heterozygous mutation of the NPHS1 gene in a Chinese child with congenital nephrotic syndrome: A case report.","date":"2023","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36800604","citation_count":2,"is_preprint":false},{"pmid":"24498843","id":"PMC_24498843","title":"NPHS1 gene mutations in children with Nephrotic Syndrome in northwest Iran.","date":"2013","source":"Pakistan journal of biological sciences : PJBS","url":"https://pubmed.ncbi.nlm.nih.gov/24498843","citation_count":2,"is_preprint":false},{"pmid":"40266336","id":"PMC_40266336","title":"The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases?","date":"2025","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40266336","citation_count":2,"is_preprint":false},{"pmid":"23829269","id":"PMC_23829269","title":"Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.","date":"2013","source":"Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis","url":"https://pubmed.ncbi.nlm.nih.gov/23829269","citation_count":2,"is_preprint":false},{"pmid":"31013750","id":"PMC_31013750","title":"The Role of p.Ser1105Ser (in NPHS1 Gene) and p.Arg548Leu (in PLCE1 Gene) with Disease Status of Vietnamese Patients with Congenital Nephrotic Syndrome: Benign or Pathogenic?","date":"2019","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/31013750","citation_count":2,"is_preprint":false},{"pmid":"37220796","id":"PMC_37220796","title":"Integrated enzyme hydrolysis assisted cellulose nanofibril (CNF) fabrication: A sustainable approach to paper mill sludge (PMS) management.","date":"2023","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/37220796","citation_count":2,"is_preprint":false},{"pmid":"28392951","id":"PMC_28392951","title":"Three Novel Mutations in the NPHS1 Gene in Vietnamese Patients with Congenital Nephrotic Syndrome.","date":"2017","source":"Case reports in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28392951","citation_count":2,"is_preprint":false},{"pmid":"39365269","id":"PMC_39365269","title":"Synthesis and Fabrication of Metal Cation Intercalation in Multilayered Ti3C2T Composite CNF Electrode for Asymmetric Coin Cell Supercapacitors.","date":"2024","source":"Langmuir : the ACS journal of surfaces and colloids","url":"https://pubmed.ncbi.nlm.nih.gov/39365269","citation_count":2,"is_preprint":false},{"pmid":"31443662","id":"PMC_31443662","title":"Congenital nephrotic syndrome associated with 22q11.2 duplication syndrome in a Chinese family and functional analysis of the intronic NPHS1 c. 3286 + 5G > A mutation.","date":"2019","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/31443662","citation_count":2,"is_preprint":false},{"pmid":"34396835","id":"PMC_34396835","title":"A case report of congenital nephrotic syndrome caused by new mutations of NPHS1.","date":"2021","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/34396835","citation_count":2,"is_preprint":false},{"pmid":"38444459","id":"PMC_38444459","title":"A Case of Congenital Nephrotic Syndrome with Crescents Caused by a Novel Compound Heterozygous Pairing of NPHS1 Genetic Variants.","date":"2024","source":"Case reports in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/38444459","citation_count":2,"is_preprint":false},{"pmid":"24231487","id":"PMC_24231487","title":"Does NPHS1 polymorphism modulate P118l mutation in NPHS2?","date":"2013","source":"Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia","url":"https://pubmed.ncbi.nlm.nih.gov/24231487","citation_count":2,"is_preprint":false},{"pmid":"24142548","id":"PMC_24142548","title":"Functional analysis of NPHS1 mutations in Japanese patients.","date":"2013","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24142548","citation_count":1,"is_preprint":false},{"pmid":"37560858","id":"PMC_37560858","title":"Three Novel Heterozygous Mutations of NPHS1 Gene Causing Infants with Congenital Nephrotic Syndrome: Two Chinese (Han) Cases.","date":"2023","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/37560858","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50423,"output_tokens":3032,"usd":0.098375,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10497,"output_tokens":3744,"usd":0.073042,"stage2_stop_reason":"end_turn"},"total_usd":0.171417,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"The NPHS1 gene encodes nephrin, a transmembrane protein expressed on podocytes. The gene consists of 29 exons spanning 26 kb on chromosome 19q13.1. Loss-of-function mutations (including the Finnish Fin-major 2-bp deletion in exon 2 and Fin-minor nonsense mutation in exon 26) cause congenital nephrotic syndrome of the Finnish type.\",\n      \"method\": \"Genomic structure analysis, direct exon sequencing, mutation characterization in 35 NPHS1 patients\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational structural characterization of the gene replicated across multiple patient cohorts and confirmed by multiple subsequent studies\",\n      \"pmids\": [\"9915943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Fin-major and Fin-minor mutations in NPHS1 both lead to complete absence of nephrin protein in podocytes and loss of podocyte slit diaphragms, while ZO-1 (another slit diaphragm-associated protein) stains normally. A patient with Fin-major/R743C genotype expressed nephrin, had normal slit diaphragms, and responded to therapy, establishing that nephrin is required for slit diaphragm formation.\",\n      \"method\": \"Immunohistochemistry, Western blotting, in situ hybridization, electron microscopy of nephrectomized kidneys from 46 Finnish NPHS1 patients\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (IHC, WB, ISH, EM) in a large patient cohort with genotype-phenotype correlation\",\n      \"pmids\": [\"10972661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Missense mutations in NPHS1 result in nephrin protein being retained in the endoplasmic reticulum (ER) and failing to reach the cell surface, indicating that defective intracellular nephrin transport (most likely due to misfolding) is the most common pathomechanism of missense mutations in NPHS1.\",\n      \"method\": \"Stable transfection of cells expressing 21 nephrin missense mutants, immunostaining, immunoelectron microscopy, subcellular fractionation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic in vitro functional analysis with multiple orthogonal methods (immunostaining, immunoelectron microscopy, subcellular fractionation) across 21 different mutations\",\n      \"pmids\": [\"11726550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recurrence of nephrotic syndrome after kidney transplantation in NPHS1 patients is caused by circulating autoantibodies against nephrin. Serial serum samples showed increased anti-nephrin antibody titers prior to nephrotic syndrome episodes and subsequent drops after successful treatment, with high-titer sera reacting with glomeruli in indirect immunofluorescence.\",\n      \"method\": \"Indirect immunofluorescence microscopy, immunoblotting, ELISA using serial serum samples from transplanted NPHS1 patients\",\n      \"journal\": \"Experimental nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (IF, immunoblot, ELISA) in a single lab with serial patient samples demonstrating correlation between antibody titer and disease recurrence\",\n      \"pmids\": [\"11549850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"An 8.3-kb fragment of the murine Nphs1 5' flanking region (promoter) drives podocyte-specific expression of a lacZ reporter transgene in kidneys, with additional expression in a discrete area of the brain medulla, establishing the Nphs1 promoter as a tool for podocyte-specific transgene expression.\",\n      \"method\": \"BAC clone identification, transgenic mouse generation with LacZ reporter, chemiluminescence assay, X-gal staining of tissue sections, developmental expression analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo localization experiment with multiple transgenic founders confirming integration-independent expression pattern\",\n      \"pmids\": [\"11095653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Anti-nephrin antibodies in NPHS1 patients homozygous for Fin-major mutation effectively impair glomerular filtration barrier function in kidney grafts, and plasma exchange alongside cyclophosphamide treatment reduces proteinuric episodes, further supporting the pathogenic role of anti-nephrin autoantibodies.\",\n      \"method\": \"ELISA for anti-nephrin antibodies, light microscopy and immunohistochemistry of kidney biopsies, clinical outcomes analysis of 65 NPHS1 patients with 77 transplants\",\n      \"journal\": \"Transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ELISA antibody quantification correlated with clinical outcomes in a substantial patient cohort, replicating the 2001 autoantibody finding\",\n      \"pmids\": [\"17519780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic evidence for a functional inter-relationship between NPHS1 (nephrin) and NPHS2 (podocin) was established through identification of a unique di-genic inheritance pattern where compound mutations in both NPHS1 and NPHS2 ('tri-allelic hit') modify the disease phenotype from congenital nephrotic syndrome to congenital focal segmental glomerulosclerosis.\",\n      \"method\": \"Genetic epistasis analysis, direct sequencing of NPHS1 and NPHS2 in 41 non-Finnish CNF patients and additional patients with FSGS\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis in human patients, single study establishing functional interaction between NPHS1 and NPHS2 at the pathway level\",\n      \"pmids\": [\"11854170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Wild-type nephrin suppresses TRPC6 channel currents in HEK293 cells and podocytes, and synonymous NPHS1 polymorphisms (rs2285450, rs437168) abolish this suppressive effect, suggesting that nephrin normally limits TRPC6 activity and that NPHS1 variants can modify the penetrance of TRPC6 mutations.\",\n      \"method\": \"Patch-clamp electrophysiology in HEK293 cells and podocytes transfected with wild-type or variant TRPC6 and NPHS1 constructs\",\n      \"journal\": \"American journal of transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct functional electrophysiology experiment in two cell systems (HEK293 and podocytes), single lab study\",\n      \"pmids\": [\"26147534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CNS-associated NPHS1 missense mutations A419T and C623F reduce nephrin surface expression, cause ER retention, impair nephrin tyrosine phosphorylation on its cytoplasmic tail, and exert dominant negative effects on wild-type nephrin signaling, revealing that extracellular domain missense mutations can disrupt intracellular nephrin signaling.\",\n      \"method\": \"Kidney biopsy immunolocalization, stable cell transfection, immunofluorescence, flow cytometry for surface expression, phosphorylation assays, dominant-negative signaling assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (IHC on biopsy, cell surface expression, phosphorylation assays, dominant-negative analysis) in a single lab\",\n      \"pmids\": [\"30212551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pathogenic NPHS1 mutations in Japanese patients impair trafficking of nephrin to the plasma membrane, confirmed by transient transfection assays comparing staining with and without detergent permeabilization (Triton X), consistent with the previously established ER-retention mechanism.\",\n      \"method\": \"Transient transfection, immunostaining with and without Triton X permeabilization, automated counting software\",\n      \"journal\": \"Histology and histopathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cell-based trafficking assay replicating prior mechanistic findings in a new cohort with a simplified method\",\n      \"pmids\": [\"24142548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nphs1 knockout mice (conditional) exhibit effacement of foot processes (mean FP density 1.0 vs. 2.0 FP/µm in controls), reduced filtration slit density, proteinuria within the first week of life, and median survival of 18 days, directly demonstrating that nephrin is required for structural integrity of the podocyte filtration barrier and normal glomerular function in vivo.\",\n      \"method\": \"Conditional Nphs1 knockout mouse model phenotyping: electron microscopy for foot process density and filtration slit density, urine albumin-to-creatinine ratio, serum albumin, BUN, creatinine\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with multiple defined phenotypic readouts (ultrastructure, proteinuria, survival, serum markers) in a single study\",\n      \"pmids\": [\"38482553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A novel intronic NPHS1 mutation (c.3286+5G>A) causes aberrant alternative splicing of NPHS1, establishing a splicing defect as a pathomechanism for congenital nephrotic syndrome in this patient.\",\n      \"method\": \"RT-PCR/splicing analysis of patient-derived samples to confirm aberrant splicing caused by the intronic mutation\",\n      \"journal\": \"Italian journal of pediatrics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single patient, single lab, splicing assay without detailed functional characterization of downstream consequences\",\n      \"pmids\": [\"31443662\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NPHS1 encodes nephrin, a transmembrane immunoglobulin-family protein essential for the structure and function of the podocyte slit diaphragm; loss-of-function mutations (including Finnish Fin-major/Fin-minor) abolish nephrin expression and slit diaphragm formation causing massive proteinuria, while most missense mutations cause ER retention and impaired surface trafficking of misfolded nephrin, nephrin also functions as a signaling scaffold whose tyrosine phosphorylation recruits intracellular effectors and whose surface expression negatively regulates TRPC6 channel activity, and its absence in NPHS1 patients treated by transplantation introduces a neoantigen that drives pathogenic anti-nephrin autoantibodies responsible for post-transplant nephrotic recurrence.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NPHS1 encodes nephrin, a podocyte transmembrane protein that is the structural cornerstone of the glomerular slit diaphragm and is required for the integrity of the kidney filtration barrier [#0, #1]. Loss-of-function mutations, including the Finnish Fin-major and Fin-minor alleles, abolish nephrin protein and slit diaphragm formation, causing congenital nephrotic syndrome of the Finnish type [#0, #1]; conditional Nphs1 knockout in mice reproduces this with foot process effacement, reduced filtration slit density, early proteinuria, and neonatal lethality [#10]. The most common pathomechanism for missense mutations is misfolding-driven endoplasmic reticulum retention that prevents nephrin from reaching the cell surface [#2, #9], and certain extracellular-domain missense mutations additionally impair tyrosine phosphorylation of the nephrin cytoplasmic tail and act dominant-negatively on wild-type nephrin signaling [#8]. Beyond its structural role, surface nephrin functions as a signaling protein whose activity suppresses TRPC6 channel currents, linking NPHS1 variants to modulation of TRPC6-dependent channel activity [#7]. In NPHS1 patients lacking nephrin, transplantation of a nephrin-bearing graft elicits pathogenic circulating anti-nephrin autoantibodies that impair the filtration barrier and drive post-transplant nephrotic recurrence [#3, #5]. Nephrin function is genetically interlinked with podocin (NPHS2), where combined NPHS1/NPHS2 mutations modify the disease phenotype [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that NPHS1 encodes a podocyte transmembrane protein and that defined loss-of-function alleles cause congenital nephrotic syndrome answered what gene underlies the Finnish-type disease.\",\n      \"evidence\": \"Genomic structure analysis and exon sequencing in 35 NPHS1 patients identifying Fin-major and Fin-minor mutations\",\n      \"pmids\": [\"9915943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular/structural role of nephrin at the slit diaphragm\", \"No mechanism for how individual mutations disrupt protein function\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that disease-causing mutations abolish nephrin protein and slit diaphragms while ZO-1 staining is preserved established that nephrin is specifically required for slit diaphragm formation.\",\n      \"evidence\": \"IHC, Western blot, in situ hybridization, and EM on nephrectomized kidneys from 46 Finnish patients with genotype-phenotype correlation\",\n      \"pmids\": [\"10972661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how nephrin organizes the slit diaphragm molecularly\", \"Did not address trafficking or signaling roles\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of a podocyte-specific Nphs1 promoter fragment provided a tool to drive podocyte-restricted transgene expression, defining the gene's tissue specificity at the regulatory level.\",\n      \"evidence\": \"Transgenic mice with an 8.3-kb Nphs1 5' promoter driving lacZ, with X-gal staining and developmental expression analysis\",\n      \"pmids\": [\"11095653\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not characterize the transcription factors controlling podocyte-specific expression\", \"Unexplained brain medulla expression\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that most missense mutants are retained in the ER and fail to reach the cell surface identified defective intracellular trafficking due to misfolding as the dominant pathomechanism of missense alleles.\",\n      \"evidence\": \"Stable transfection of 21 nephrin missense mutants with immunostaining, immunoelectron microscopy, and subcellular fractionation\",\n      \"pmids\": [\"11726550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the ER quality-control machinery involved\", \"Did not test whether residual surface protein retains signaling function\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linking post-transplant nephrotic recurrence to circulating anti-nephrin antibodies established an autoimmune neoantigen mechanism in nephrin-null patients.\",\n      \"evidence\": \"Indirect immunofluorescence, immunoblotting, and ELISA on serial sera from transplanted NPHS1 patients with titer-disease correlation\",\n      \"pmids\": [\"11549850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab correlative data without proof of direct pathogenic causation\", \"Antibody epitopes on nephrin not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery of tri-allelic NPHS1/NPHS2 inheritance modifying the phenotype established a functional pathway-level interaction between nephrin and podocin.\",\n      \"evidence\": \"Genetic epistasis analysis and sequencing of NPHS1 and NPHS2 in non-Finnish CNF and FSGS patients\",\n      \"pmids\": [\"11854170\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not demonstrate physical or biochemical interaction between nephrin and podocin\", \"Mechanism of phenotype modification unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Correlating anti-nephrin antibody titers with graft filtration impairment and treatment response reinforced the pathogenic role of the autoantibodies and informed therapeutic intervention.\",\n      \"evidence\": \"ELISA antibody quantification with biopsy IHC and clinical outcomes in 65 patients across 77 transplants, including plasma exchange and cyclophosphamide\",\n      \"pmids\": [\"17519780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative clinical data rather than direct mechanistic proof\", \"Did not define how antibody binding disrupts barrier function molecularly\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Replication of impaired plasma-membrane trafficking in a Japanese cohort confirmed ER retention as a conserved pathomechanism across populations.\",\n      \"evidence\": \"Transient transfection with permeabilized/non-permeabilized immunostaining and automated counting\",\n      \"pmids\": [\"24142548\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Simplified assay without quantitative surface trafficking measures\", \"No downstream functional consequence assessed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that nephrin suppresses TRPC6 channel currents and that synonymous NPHS1 polymorphisms abolish this effect revealed a signaling/channel-regulatory function for nephrin beyond its structural role.\",\n      \"evidence\": \"Patch-clamp electrophysiology in HEK293 cells and podocytes co-expressing TRPC6 and NPHS1 constructs\",\n      \"pmids\": [\"26147534\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study; molecular mechanism of TRPC6 suppression not defined\", \"In vivo relevance of polymorphism effects not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showing that extracellular-domain missense mutations reduce surface expression, impair cytoplasmic-tail phosphorylation, and act dominant-negatively connected trafficking defects to disrupted nephrin signaling.\",\n      \"evidence\": \"Biopsy immunolocalization, stable transfection, flow cytometry surface assays, phosphorylation and dominant-negative signaling assays\",\n      \"pmids\": [\"30212551\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling effectors of the phosphorylated tail not identified\", \"Single-lab analysis of two mutations\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of an intronic mutation causing aberrant splicing extended the mutational spectrum of NPHS1 to splicing defects.\",\n      \"evidence\": \"RT-PCR/splicing analysis of patient-derived samples\",\n      \"pmids\": [\"31443662\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single patient, single lab without functional characterization of downstream protein consequences\", \"Transcript fate and residual protein not quantified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Conditional Nphs1 knockout mice with foot process effacement, proteinuria, and early lethality provided direct in vivo confirmation that nephrin is required for filtration barrier integrity and glomerular function.\",\n      \"evidence\": \"Conditional knockout phenotyping with EM ultrastructure, urine albumin-to-creatinine ratio, and serum markers\",\n      \"pmids\": [\"38482553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not dissect structural versus signaling contributions in vivo\", \"Mechanism connecting nephrin loss to foot process effacement not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The intracellular effectors recruited by phosphorylated nephrin and the precise molecular mechanism by which nephrin organizes the slit diaphragm and regulates TRPC6 remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No identified downstream signaling partners of the nephrin cytoplasmic tail in the corpus\", \"No structural model of the nephrin-based slit diaphragm\", \"Molecular basis of TRPC6 suppression unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 1, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 8]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"complexes\": [\"slit diaphragm\"],\n    \"partners\": [\"TRPC6\", \"NPHS2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}